{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "regularMarketChangePercent": 0.0, "regularMarketPrice": 2.16, "earningsTimestamp": 1683894600, "earningsTimestampStart": 1683894600, "earningsTimestampEnd": 1683894600, "trailingAnnualDividendRate": 0.0, "trailingPE": 2.3225808, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": 0.93, "sharesOutstanding": 25077500, "bookValue": 2.557, "fiftyDayAverage": 2.3314, "fiftyDayAverageChange": -0.17139983, "fiftyDayAverageChangePercent": -0.073517986, "twoHundredDayAverage": 2.295185, "twoHundredDayAverageChange": -0.135185, "twoHundredDayAverageChangePercent": -0.05889939, "marketCap": 55727572, "priceToBook": 0.84474, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1078470000000, "priceHint": 4, "marketState": "REGULAR", "exchange": "FRA", "shortName": "CIPHER PHARMACEUTICALS", "longName": "Cipher Pharmaceuticals Inc.", "messageBoardId": "finmb_8201659", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChange": 0.0, "regularMarketTime": 1683880220, "regularMarketDayHigh": 2.16, "regularMarketDayRange": "2.16 - 2.16", "regularMarketDayLow": 2.16, "regularMarketVolume": 250, "regularMarketPreviousClose": 2.16, "bid": 2.34, "ask": 2.42, "bidSize": 463, "askSize": 437, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 2.16, "averageDailyVolume3Month": 11, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.6700001, "fiftyTwoWeekLowChangePercent": 0.44966447, "fiftyTwoWeekRange": "1.49 - 2.7", "fiftyTwoWeekHighChange": -0.53999996, "fiftyTwoWeekHighChangePercent": -0.19999999, "fiftyTwoWeekLow": 1.49, "fiftyTwoWeekHigh": 2.7, "symbol": "PHE.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "5750 Explorer Drive", "address2": "Suite 404", "city": "Mississauga", "state": "ON", "zip": "L4W 0A9", "country": "Canada", "phone": "905-602-5840", "website": "https://www.cipherpharma.com", "industry": "Drug Manufacturers\u2014Specialty & Generic", "industryDisp": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. It offers Epuris (isotretinoin), an oral retinoid indicated for the treatment of severe nodular and/or inflammatory acne, acne conglobate, and recalcitrant acne; Actikerall, which is indicated for the treatment of palpable or moderately thick hyperkeratotic actinic keratosis; Ozanex for the topical treatment of impetigo; Vaniqa, a topical cream for the slowing of the growth of unwanted facial hair in women; Durela, an opioid analgesic for the management of moderate to moderately severe pain in adults; Brinavess for the rapid conversion of onset atrial fibriallation to sinus rhythm in adults; and Aggrastat, a reversible GP IIb/IIIa inhibitor for use in patients with Acute Coronary Syndrome. The company's licensed products comprise Absorica, an oral retinoid indicated for the treatment of severe recalcitrant nodular acne; Lipofe indicated as adjunctive therapy to diet to reduce triglycerides in adult patients with severe hypertriglyceridemia; and Conzip, an opioid agonist indicated for the management of moderate to moderately severe chronic pain in adults. Its pipeline products include CF-101 for severe plaque psoriasis and rheumatoid arthritis; MOB-015, a topical formulation of terbinafine for treatment of onychomycosis; and DTR-001, a tattoo removal cream. Cipher Pharmaceuticals Inc. was founded in 2000 and is headquartered in Mississauga, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Craig J. Mull", "title": "Interim CEO & Chairman", "fiscalYear": 2021, "totalPay": {"raw": 72236, "fmt": "72.24k", "longFmt": "72,236"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Diane  Gajewczyk", "title": "VP of Scientific & Medical Affairs", "fiscalYear": 2021, "totalPay": {"raw": 210149, "fmt": "210.15k", "longFmt": "210,149"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Bryan  Jacobs", "title": "Chief Financial Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Emilio  Presti", "title": "Director of Sales & Marketing", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1640908800, "maxAge": 86400}}], "error": null}}